Inactive Instrument

Company bioMérieux Euronext Paris

Equities

FR0010096479

Medical Equipment, Supplies & Distribution

Business Summary

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows:

- medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors;

- industrial applications (15.6%).

The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services.

Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).

Sales per Business

EUR in Million2022Weight2023Weight Delta
Clinical Applications
84.3 %
3,040 84.7 % 3,099 84.3 % +1.95%
Industrial Applications
15.7 %
549 15.3 % 575 15.7 % +4.79%

Sales per region

EUR in Million2022Weight2023Weight Delta
Americas
50.2 %
1,841 51.3 % 1,846 50.2 % +0.26%
EMEA
26.3 %
901 25.1 % 965 26.3 % +7.05%
Asia Pacific
17.4 %
624 17.4 % 638 17.4 % +2.15%
France
6.1 %
220 6.1 % 226 6.1 % +2.64%
Corporate
0.0 %
3 0.1 % 1 0.0 % -65.38%

Managers

Managers TitleAgeSince
Chief Executive Officer 52 16-10-31
Chairman 50 04-04-15
Director of Finance/CFO 47 18-02-28
Chief Tech/Sci/R&D Officer - 23-07-31
Director/Board Member 74 06-09-14
Public Communications Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal 44 10-12-31
Corporate Officer/Principal 58 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 74 06-09-14
Director/Board Member 63 04-12-31
Chairman 50 04-04-15
Director/Board Member 59 12-05-29
Director/Board Member 59 12-05-29
Director/Board Member 45 17-06-29
Director/Board Member 68 17-08-27
Director/Board Member - 22-05-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 118,361,220 42,032,182 ( 35.51 %) 206,987 ( 0.1749 %) 35.51 %

Shareholders

NameEquities%Valuation
Compagnie Merieux Alliance SAS
58.90 %
69,720,270 58.90 % 7 699 M €
5,440,410 4.596 % 601 M €
Oddo BHF Asset Management SAS
1.893 %
2,240,867 1.893 % 247 M €
Sofina SA (Private Equity)
1.729 %
2,046,857 1.729 % 226 M €
bioMérieux SA Employee Stock Ownership Plan
0.7231 %
855,920 0.7231 % 95 M €
DNCA Finance SA
0.4779 %
565,630 0.4779 % 62 M €
Crédit Mutuel Asset Management SA
0.4613 %
545,975 0.4613 % 60 M €
Amundi Asset Management SA (Investment Management)
0.3743 %
443,052 0.3743 % 49 M €
AXA France Assurance SAS
0.3723 %
440,631 0.3723 % 49 M €
BIOMÉRIEUX
0.3711 %
439,225 0.3711 % 49 M €

Holdings

NameEquities%Valuation
59,062,832 6.87% 90,652,588 $
439,225 0.37% 48,503,617 $

Company contact information

bioMérieux SA

376, chemin de l'Orme

69280, Marcy l'Etoile

+33 4 78 87 20 00

http://www.biomerieux.com
address bioMérieux

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Medical Specialties
Packaged Software
Electronic Production Equipment
Medical Specialties
bioMérieux Sweden AB
Medical Specialties
Medical Specialties
Medical Distributors